Comparative Study of Intermittent Catheters and Occurrence of Urinary Tract Infections
A Prospective, Randomized, Parallel-group, Multi-center Study to Compare the Occurrence of Urinary Tract Infections in Patients With Spinal Cord Injury Using Either Coated or Uncoated Intermittent Catheters.
1 other identifier
interventional
219
2 countries
16
Brief Summary
The purpose of this study is to investigate the frequency of urinary tract infections with symptoms in spinal cord injured patients requiring intermittent catheterization for emptying the bladder. Patients will use either a coated catheter or an uncoated catheter with gel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2006
Longer than P75 for not_applicable
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
April 26, 2006
CompletedFirst Posted
Study publicly available on registry
April 27, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedResults Posted
Study results publicly available
May 25, 2011
CompletedFebruary 10, 2021
August 1, 2015
3.5 years
April 26, 2006
February 23, 2011
January 26, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Occurrence of Symptomatic Urinary Tract Infections (UTIs)
Occurrence of symptomatic urinary tract infections (UTIs). Time to first UTI
4-6 months
Secondary Outcomes (6)
UTIs With Bacteriuria >=100 Colony Forming Units (CFU)/ml
4-6 months
Nurse Evaluation of Catheters - Overall Satisfaction
4-6 months
Patient or Caregiver's Evaluation of Catheters - Overall Satisfaction
4-6 months
Nurse Time Spent on Catheterization Procedure
4-6 months
Device-related or Possibly Device-related AEs
4-6 months
- +1 more secondary outcomes
Study Arms (2)
SpeediCath
EXPERIMENTALhydrophilic-coated intermittent catheter
Conveen Uncoated
EXPERIMENTALuncoated urinary intermittent catheter
Interventions
hydrophilic coated urinary intermittent catheter
Uncoated urinary intermittent catheter
Eligibility Criteria
You may qualify if:
- Neurogenic bladder dysfunction requiring intermittent catheterization at least 3 times daily
You may not qualify if:
- Treated with prophylactic antibiotics to prevent UTIs
- Has a history of unresolved bladder-ureteral reflux and/or stones in the urinary tract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
Study Sites (16)
Rancho Los Amigos National Rehabilitation Center
Downey, California, 90242, United States
Santa Clara Valley Medical Center
San Jose, California, 95128, United States
Craig Hospital
Englewood, Colorado, 80113, United States
University of Miami
Miami, Florida, 33101, United States
Shepherd Center
Atlanta, Georgia, 30309, United States
Boston Medical School
Boston, Massachusetts, 02188, United States
University of Michigan Helaths Systems
Ann Arbor, Michigan, 48108, United States
Mayo Clinic, Saint Mary Hospital MB3CF Rehabilitation
Rochester, Minnesota, 55902, United States
Kessler Institute for Rehabilitation
West Orange, New Jersey, 07052, United States
Mount Sinai School of Medicine
New York, New York, 10029, United States
Carolinas Medical Center
Charlotte, North Carolina, 28303, United States
The Institute for Rehabilitation and Research (TIRR)
Houston, Texas, 77030, United States
University of Alberta
Edmonton, Alberta, T6G 2C8, Canada
G.F.Strong Rehabilitation Centre
Vancouver, British Columbia, V5Z 2G9, Canada
Parkwood Rehabilitation Centre
London, Ontario, N6A 4G5, Canada
Toronto Rehabilitation Centre
Toronto, Ontario, M4G 3V9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Anna Karina Busch, Intl. Senior Scientific Manager
- Organization
- Coloplast
Study Officials
- PRINCIPAL INVESTIGATOR
Diana Cardenas, MD
University of Miami
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2006
First Posted
April 27, 2006
Study Start
April 1, 2006
Primary Completion
October 1, 2009
Study Completion
October 1, 2009
Last Updated
February 10, 2021
Results First Posted
May 25, 2011
Record last verified: 2015-08